Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Tilray, Inc.
  6. News
  7. Summary
    TLRY   US88688T1007

TILRAY, INC.

(TLRY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

TILRAY : ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF STOCKHOLDERS TO AUGUST 19, 2021 (Form 8-K)

07/29/2021 | 05:59pm EDT
TILRAY ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF STOCKHOLDERS TO AUGUST 19, 2021

Preliminary assessment of votes already cast points to overwhelming support for both the Authorized Shares Proposal and the Governance Proposals

Tilray urges stockholders to vote immediately in support of long-term value creation

NEW YORK & LEAMINGTON, Ontario--(BUSINESS WIRE)--Tilray, Inc. ('Tilray' or the 'Company') (NASDAQ | TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today convened and then adjourned the Special Meeting of Stockholders intended to approve two shareholder proposals: (1) a proposal to increase the authorized number of shares of common stock ('Authorized Shares Proposal'); and (2) a number of governance enhancements to increase stockholder rights (the 'Governance Proposals'). The Special Meeting was adjourned to August 19, 2021, at 11:00 a.m. Eastern Time.

Based on a preliminary assessment of votes received by the Company's proxy solicitor, the overwhelming majority of votes cast to date support both the Authorized Shares Proposal and the Governance Proposals. The adjournment of the Special Meeting is intended to provide Tilray with additional time to solicit proxies to ensure that all Tilray stockholders have an opportunity to make their voices heard.

'The level of support we have received from stockholders thus far affirms that participating shareholders strongly support the two proposals,' said Irwin D. Simon, Tilray's Chairman and Chief Executive Officer. 'This support is logical, as the Authorized Shares Proposal is a critical part of our strategy to capture market share and drive profitable growth and the Governance Proposals are aimed at providing our stockholders more rights to hold management and the Board accountable.'

Mr. Simon continued, 'We urge stockholders who have not yet voted to participate in the success of their investment in Tilray by voting FOR all proposals on the agenda for the Special Meeting. By doing so, stockholders will be actively participating in Tilray's ability to capitalize on substantial growth opportunities, expand and generate strong performance, increase stockholder rights and, ultimately, drive stockholder value. No matter how many or how few shares you own, your participation is vital to our success.'

The approval of the Authorized Shares Proposal requires the affirmative vote of holders of at least a majority of the voting power of shares outstanding and entitled to vote. The record date for the adjourned Special Meeting remains June 22, 2021. Stockholders who have already voted do not need to recast their votes unless they wish to change their vote. Stockholders who have not already voted or wish to change their vote are strongly encouraged to do so promptly using the instructions provided in their voting instruction form or proxy card.

If you have any questions, or need any assistance in voting your shares, please contact Morrow Sodali LLC at (833) 497-7395 toll-free in the U.S. and Canada, or (203) 658-9400 or by email at TLRY@info.morrowsodali.com.

HELP TILRAY GROW!
VOTE 'FOR' TODAY!

About Tilray

Tilray, Inc. is a leading global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people's lives for the better - one person at a time - by inspiring and empowering the worldwide community to live their very best life by providing them with products that meet the needs of their mind, body, and soul and invoke a sense of wellbeing. Tilray's mission is to be the trusted partner for its patients and consumers by providing them with a cultivated experience and health and wellbeing through high-quality, differentiated brands and innovative products. A pioneer in cannabis research, cultivation, and distribution, Tilray's unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and alcoholic beverages.

For more information about Tilray, Inc., visit: http://www.Tilray.com

Forward-Looking Statements

Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, 'forward-looking statements') under Canadian securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the 'safe harbor' created by those sections and other applicable laws. Forward-looking statements can be identified by words such as 'forecast,' 'future,' 'should,' 'could,' 'enable,' 'potential,' 'contemplate,' 'believe,' 'anticipate,' 'estimate,' 'plan,' 'expect,' 'intend,' 'may,' 'project,' 'will,' 'would' and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses or current expectations concerning, among other things, the need for an increase in authorized shares of common stock from 743,333,333 shares to 990,000,000 shares and the potential negative impacts to the company if the corresponding proposal is not approved. Certain material factors, estimates, goals, projections or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Many factors could cause actual results, performance or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Aphria and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with applicable securities regulatory authorities and available on SEDAR and EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities laws.

Contacts

For media inquiries, please contact:
Berrin Noorata
news@tilray.com

For investor inquiries, please contact:
Raphael Gross 203-682-8253
Raphael.Gross@icrinc.com

Disclaimer

Tilray Inc. published this content on 29 July 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 July 2021 21:55:32 UTC.


© Publicnow 2021
All news about TILRAY, INC.
09/17TILRAY, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
09/17TILRAY : ROSE LifeScience Announces Expanded Distribution Partnership with Tilra..
AQ
09/17TILRAY : Cantor Fitzgerald Trims Price Target on Tilray to $18 From $19, Keeps O..
MT
09/16TILRAY : Roth Capital Adjusts Tilray Inc PT to $12 From $25, Maintains Neutral R..
MT
09/16APHRIA : Ontario Superior Court Conditionally Certifies Securities Class Action ..
AQ
09/10TILRAY : STOCKHOLDERS APPROVE PROPOSAL TO INCREASE AUTHORIZED SHARES AT SPECIAL ..
PU
09/10TILRAY, INC. : Submission of Matters to a Vote of Security Holders, Financial St..
AQ
09/10TILRAY : Receives Stockholder Approval to Increase Authorized Shares; Falls 1.2%
MT
09/10TILRAY : Stockholders Approve Proposal to Increase Share Count, Closer to Goal o..
MT
09/10TILRAY : Stockholders Approve Proposal to Increase Authorized Shares at Special ..
BU
More news
Analyst Recommendations on TILRAY, INC.
More recommendations
Financials (USD)
Sales 2022 1 033 M - -
Net income 2022 104 M - -
Net Debt 2022 - - -
P/E ratio 2022 58,0x
Yield 2022 -
Capitalization 5 467 M 5 467 M -
Capi. / Sales 2022 5,29x
Capi. / Sales 2023 4,10x
Nbr of Employees 2 100
Free-Float 96,3%
Chart TILRAY, INC.
Duration : Period :
Tilray, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TILRAY, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Last Close Price 12,17 $
Average target price 17,67 $
Spread / Average Target 45,2%
EPS Revisions
Managers and Directors
Irwin David Simon Chairman & Chief Executive Officer
Carl A. Merton Chief Financial Officer
Joshua Eades Chief Science Officer
Catherine Jacobson Vice President-Regulatory & Medical Affairs
Lloyd Brathwaite Chief Information Officer
Sector and Competitors
1st jan.Capi. (M$)
TILRAY, INC.47.34%5 467
JOHNSON & JOHNSON4.68%433 701
ROCHE HOLDING AG10.97%321 442
PFIZER, INC.20.81%246 078
NOVO NORDISK A/S50.80%232 556
ELI LILLY AND COMPANY36.28%208 604